Literature DB >> 21900255

Expanded CUG repeats Dysregulate RNA splicing by altering the stoichiometry of the muscleblind 1 complex.

Sharan Paul1, Warunee Dansithong, Sonali P Jog, Ian Holt, Saloni Mittal, J David Brook, Glenn E Morris, Lucio Comai, Sita Reddy.   

Abstract

To understand the role of the splice regulator muscleblind 1 (MBNL1) in the development of RNA splice defects in myotonic dystrophy I (DM1), we purified RNA-independent MBNL1 complexes from normal human myoblasts and examined the behavior of these complexes in DM1 myoblasts. Antibodies recognizing MBNL1 variants (MBNL1(CUG)), which can sequester in the toxic CUG RNA foci that develop in DM1 nuclei, were used to purify MBNL1(CUG) complexes from normal myoblasts. In normal myoblasts, MBNL1(CUG) bind 10 proteins involved in remodeling ribonucleoprotein complexes including hnRNP H, H2, H3, F, A2/B1, K, L, DDX5, DDX17, and DHX9. Of these proteins, only MBNL1(CUG) colocalizes extensively with DM1 CUG foci (>80% of foci) with its partners being present in <10% of foci. Importantly, the stoichiometry of MBNL1(CUG) complexes is altered in DM1 myoblasts, demonstrating an increase in the steady state levels of nine of its partner proteins. These changes are recapitulated by the expression of expanded CUG repeat RNA in Cos7 cells. Altered stoichiometry of MBNL1(CUG) complexes results from aberrant protein synthesis or stability and is unlinked to PKCα function. Modeling these changes in normal myoblasts demonstrates that increased levels of hnRNP H, H2, H3, F, and DDX5 independently dysregulate splicing in overlapping RNA subsets. Thus expression of expanded CUG repeats alters the stoichiometry of MBNL1(CUG) complexes to allow both the reinforcement and expansion of RNA processing defects.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21900255      PMCID: PMC3207417          DOI: 10.1074/jbc.M111.255224

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

1.  RNA steady-state defects in myotonic dystrophy are linked to nuclear exclusion of SHARP.

Authors:  Warunee Dansithong; Sonali P Jog; Sharan Paul; Robabeh Mohammadzadeh; Stephanie Tring; Yukwah Kwok; Rebecca C Fry; Paul Marjoram; Lucio Comai; Sita Reddy
Journal:  EMBO Rep       Date:  2011-07-01       Impact factor: 8.807

2.  Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy.

Authors:  R S Savkur; A V Philips; T A Cooper
Journal:  Nat Genet       Date:  2001-09       Impact factor: 38.330

3.  Muscleblind proteins regulate alternative splicing.

Authors:  Thai H Ho; Nicolas Charlet-B; Michael G Poulos; Gopal Singh; Maurice S Swanson; Thomas A Cooper
Journal:  EMBO J       Date:  2004-07-15       Impact factor: 11.598

4.  Myotonic dystrophy mutation: an unstable CTG repeat in the 3' untranslated region of the gene.

Authors:  M Mahadevan; C Tsilfidis; L Sabourin; G Shutler; C Amemiya; G Jansen; C Neville; M Narang; J Barceló; K O'Hoy
Journal:  Science       Date:  1992-03-06       Impact factor: 47.728

5.  An unstable triplet repeat in a gene related to myotonic muscular dystrophy.

Authors:  Y H Fu; A Pizzuti; R G Fenwick; J King; S Rajnarayan; P W Dunne; J Dubel; G A Nasser; T Ashizawa; P de Jong
Journal:  Science       Date:  1992-03-06       Impact factor: 47.728

6.  Muscleblind protein, MBNL1/EXP, binds specifically to CHHG repeats.

Authors:  Yoshihiro Kino; Daisuke Mori; Yoko Oma; Yuya Takeshita; Noboru Sasagawa; Shoichi Ishiura
Journal:  Hum Mol Genet       Date:  2004-01-13       Impact factor: 6.150

7.  A muscleblind knockout model for myotonic dystrophy.

Authors:  Rahul N Kanadia; Karen A Johnstone; Ami Mankodi; Codrin Lungu; Charles A Thornton; Douglas Esson; Adrian M Timmers; William W Hauswirth; Maurice S Swanson
Journal:  Science       Date:  2003-12-12       Impact factor: 47.728

8.  Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy.

Authors:  Ami Mankodi; Masanori P Takahashi; Hong Jiang; Carol L Beck; William J Bowers; Richard T Moxley; Stephen C Cannon; Charles A Thornton
Journal:  Mol Cell       Date:  2002-07       Impact factor: 17.970

9.  Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing.

Authors:  Nicolas Charlet-B; Rajesh S Savkur; Gopal Singh; Anne V Philips; Elizabeth A Grice; Thomas A Cooper
Journal:  Mol Cell       Date:  2002-07       Impact factor: 17.970

10.  Increased steady-state levels of CUGBP1 in myotonic dystrophy 1 are due to PKC-mediated hyperphosphorylation.

Authors:  N Muge Kuyumcu-Martinez; Guey-Shin Wang; Thomas A Cooper
Journal:  Mol Cell       Date:  2007-10-12       Impact factor: 17.970

View more
  35 in total

1.  Overexpression of Staufen1 in DM1 mouse skeletal muscle exacerbates dystrophic and atrophic features.

Authors:  Tara E Crawford Parks; Kristen A Marcellus; Christine Péladeau; Bernard J Jasmin; Aymeric Ravel-Chapuis
Journal:  Hum Mol Genet       Date:  2020-08-03       Impact factor: 6.150

2.  Pharmacological and physiological activation of AMPK improves the spliceopathy in DM1 mouse muscles.

Authors:  Aymeric Ravel-Chapuis; Ali Al-Rewashdy; Guy Bélanger; Bernard J Jasmin
Journal:  Hum Mol Genet       Date:  2018-10-01       Impact factor: 6.150

Review 3.  Myotonic dystrophy: is a narrow focus obscuring the rest of the field?

Authors:  Mani S Mahadevan
Journal:  Curr Opin Neurol       Date:  2012-10       Impact factor: 5.710

Review 4.  RNA toxicity and foci formation in microsatellite expansion diseases.

Authors:  Nan Zhang; Tetsuo Ashizawa
Journal:  Curr Opin Genet Dev       Date:  2017-02-14       Impact factor: 5.578

5.  Reduction of toxic RNAs in myotonic dystrophies type 1 and type 2 by the RNA helicase p68/DDX5.

Authors:  Karlie Jones; Christina Wei; Benedikt Schoser; Giovanni Meola; Nikolai Timchenko; Lubov Timchenko
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-15       Impact factor: 11.205

Review 6.  RNA-binding protein misregulation in microsatellite expansion disorders.

Authors:  Marianne Goodwin; Maurice S Swanson
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

7.  Alternative Splicing of Neuronal Differentiation Factor TRF2 Regulated by HNRNPH1/H2.

Authors:  Ioannis Grammatikakis; Peisu Zhang; Amaresh C Panda; Jiyoung Kim; Stuart Maudsley; Kotb Abdelmohsen; Xiaoling Yang; Jennifer L Martindale; Omar Motiño; Emmette R Hutchison; Mark P Mattson; Myriam Gorospe
Journal:  Cell Rep       Date:  2016-04-21       Impact factor: 9.423

8.  Nuclear ARVCF protein binds splicing factors and contributes to the regulation of alternative splicing.

Authors:  Ulrike Rappe; Tanja Schlechter; Moritz Aschoff; Agnes Hotz-Wagenblatt; Ilse Hofmann
Journal:  J Biol Chem       Date:  2014-03-18       Impact factor: 5.157

9.  New function for the RNA helicase p68/DDX5 as a modifier of MBNL1 activity on expanded CUG repeats.

Authors:  François-Xavier Laurent; Alain Sureau; Arnaud F Klein; François Trouslard; Erwan Gasnier; Denis Furling; Joëlle Marie
Journal:  Nucleic Acids Res       Date:  2011-12-09       Impact factor: 16.971

10.  hnRNP L is essential for myogenic differentiation and modulates myotonic dystrophy pathologies.

Authors:  Matthew S Alexander; Rylie M Hightower; Andrea L Reid; Alexis H Bennett; Lakshmanan Iyer; Donna K Slonim; Madhurima Saha; Genri Kawahara; Louis M Kunkel; Alan S Kopin; Vandana A Gupta; Peter B Kang; Isabelle Draper
Journal:  Muscle Nerve       Date:  2021-03-22       Impact factor: 3.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.